Published On: June 18th, 2010
The already-approved products in the Rare Disease Repurposing Database are unique in that they’ve also previously received orphan-drug designation.

Original post:
FDA Database Aims to Spark Orphan-Disease Drug Development
Loading...
Leave a comment



Did you know:






